N. Mwelase

发表

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort

R. Bollinger, R. Shivakoti, D. Asmuth, 2016, Open forum infectious diseases.

Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation.

R. Bollinger, R. Shivakoti, J. Currier, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study

D. Dowdy, R. Shivakoti, T. Campbell, 2017, Journal of acquired immune deficiency syndromes.

Pre-Antiretroviral Therapy Serum Selenium Concentrations Predict WHO Stages 3, 4 or Death but not Virologic Failure Post-Antiretroviral Therapy

R. Shivakoti, T. Campbell, R. Semba, 2014, Nutrients.

Change in Vitamin D Levels Occurs Early after Antiretroviral Therapy Initiation and Depends on Treatment Regimen in Resource-Limited Settings

T. Campbell, J. Lama, Amita Gupta, 2014, PloS one.

Prevalence and risk factors of micronutrient deficiencies pre- and post-antiretroviral therapy (ART) among a diverse multicountry cohort of HIV-infected adults.

R. Shivakoti, T. Campbell, R. Semba, 2016, Clinical nutrition.

Evolocumab in HIV-Infected Patients With Dyslipidemia

Paul D. Thompson, S. Trottier, C. Fichtenbaum, 2020, Journal of the American College of Cardiology.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study

R. Bollinger, R. Shivakoti, T. Campbell, 2018, BMC Medicine.

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

R. Bollinger, D. Asmuth, K. Erlandson, 2016, The Journal of infectious diseases.

In ﬂ ammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults

R. Bollinger, D. Asmuth, D. Thomas, 2016 .

Virologic outcomes in early antiretroviral treatment: HPTN 052

J. Gallant, Myron S. Cohen, K. Mayer, 2017, HIV clinical trials.

D. Asmuth, J. Currier, S. Cohn, 2016, Journal of acquired immune deficiency syndromes.

C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings

R. Bollinger, D. Dowdy, D. Asmuth, 2015, PloS one.

One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis

R. Chaisson, S. Swindells, C. Fletcher, 2019, The New England journal of medicine.

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial

W. Wachsman, C. Rinaldo, C. Moser, 2020, The Lancet.

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.

R. Chaisson, S. Swindells, C. Fletcher, 2020, The Journal of antimicrobial chemotherapy.

Dolutegravir-Based Antiretroviral Therapy for Patients Co-Infected with Tuberculosis and Hiv: A Multicenter, Noncomparative, Open-Label, Randomized Trial.

K. Dooley, E. Ticona, O. Sued, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Dolutegravir-based Antiretroviral Therapy for Patients Coinfected With Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial

K. Dooley, E. Ticona, O. Sued, 2019 .

Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings.

R. Bollinger, R. Shivakoti, T. Campbell, 2016, The Journal of infectious diseases.

As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial

Jeffrey N. Martin, Minhee Kang, D. Dittmer, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.

J. Lundgren, J. Neaton, B. Grund, 2018, The lancet. HIV.

Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine

R. Chaisson, D. Haas, S. Swindells, 2020, Pharmacogenetics and genomics.

Early progression and immune reconstitution inflammatory syndrome during treatment of mild-to-moderate Kaposi sarcoma in sub-Saharan Africa and South America: Incidence, long-term outcomes and effects of early chemotherapy.

Minhee Kang, D. Dittmer, O. Martínez-Maza, 2020, Journal of acquired immune deficiency syndromes.

DOLUTEGRAVIR-BASED ANTIRETROVIRAL THERAPY FOR PATIENTS CO-INFECTED WITH TUBERCULOSIS AND HIV: A MULTICENTER, NONCOMPARATIVE, OPEN-LABEL, RANDOMIZED TRIAL

Aboud, K. Dooley, E. Ticona, 2019 .

Evolocumab Use in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-blind BEIJERINCK Study.

S. Trottier, C. Fichtenbaum, C. Katlama, 2020, Journal of the American College of Cardiology.

One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis

R. Chaisson, S. Swindells, C. Fletcher, 2019, The New England journal of medicine.

Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings

O. Martínez-Maza, Jeannette Y Lee, T. Campbell, 2023, Journal of acquired immune deficiency syndromes.

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

R. Bollinger, D. Asmuth, L. Smeaton, 2016, The Journal of infectious diseases.